Cargando…
Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to hypomethylating agents (HMA) is unknown. The prognostic impact of the revised International Prognostic Scoring System (IPSS-R) and for chromosomal translocations was assess...
Autores principales: | Suh, Koung Jin, Cheong, June-Won, Kim, Inho, Kim, Hyeoung-Joon, Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Min, Yoo Hong, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Lee, Yun-Gyoo, Lee, Jeong-Ok, Bang, Soo-Mee, Mun, Yeung-Chul, Seong, Chu-Myoung, Park, Yong, Kim, Byung-Soo, Hong, Junshik, Park, Jinny, Lee, Jae Hoon, Kim, Sung-Yong, Lee, Hong Ghi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100959/ https://www.ncbi.nlm.nih.gov/pubmed/27824923 http://dx.doi.org/10.1371/journal.pone.0166245 |
Ejemplares similares
-
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
por: Choi, Mihong, et al.
Publicado: (2020) -
Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype
por: Kim, Sang-A, et al.
Publicado: (2018) -
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020) -
Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
por: Park, Songyi, et al.
Publicado: (2021) -
Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Lee, Ahreum, et al.
Publicado: (2020)